No Evidence Exists for Methylation Inactivation of thep16Tumor Suppressor Gene in Ovarian Carcinogenesis

This publication has 17 references indexed in Scilit:

• Inactivation ofp16/CDKN2 andp15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors
  International Journal of Cancer, 1996
• Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours
  British Journal of Cancer, 1996
• Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers
  Cancer Letters, 1996
• Alterations of the p15, p16, and p18 genes in osteosarcoma
  Cancer Genetics and Cytogenetics, 1996
• High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci
  British Journal of Cancer, 1996
• Compilation of somatic mutations of theCDKN2 gene in human cancers: Non-random distribution of base substitutions
  Genes, Chromosomes and Cancer, 1996
• Alterations of CDKN2 (p16) in non‐small cell lung cancer
  Genes, Chromosomes and Cancer, 1995
• Loh and mutation analysis of CDKN2 in primary human ovarian cancers
  International Journal of Cancer, 1995
• Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood
  Blood, 1995
• Homozygous deletions within human chromosome band 9p21 in melanoma.
  Proceedings of the National Academy of Sciences, 1992